PortfolioAI equity research · September 23, 2026 · NYSE: VVX
V2X: Defense Contract Visibility Meets a Cash-Conversion Test
A new Iraq F-16 support ceiling makes the backlog story more interesting. It does not make the entire ceiling revenue.
Executive summary
Rating: Hold / watch for a better entry. V2X closed September 23 at $74.94. The defense-services franchise is generating nearly $4.90 billion in trailing revenue, but its 1.88% net margin and roughly $896 million net debt leave little room for program slippage. A recently reported up-to-$231.8 million Iraq F-16 base-support modification adds possible work through July 2027; its not-to-exceed value is neither an immediate funded order nor guaranteed profit. The better question is whether awarded work turns into cash while leverage falls.
The evidence needed to upgrade: definitive funding and margin visibility on new programs, a rebound in cash conversion, and sustained debt reduction. A confirmed loss or materially weaker profitability on a major recompete would invalidate the constructive case.
Price and trend: the last 90 calendar days
Daily closes June 25–September 23, 2026; KAMA (14) and 50-session simple moving average in dollars. The 50-session average begins only after 50 observations. Source: PortfolioAI market series; 50-session average calculated from daily closes.
Company overview and the contract thesis
Reston-based V2X provides defense and government customers with mission support, logistics, supply-chain management, platform renewal and modernization. This is a labor- and execution-heavy services business rather than a weapons-platform manufacturer. Its competitive advantage lies in operating embedded programs across geographies and keeping mission-critical activities running; the trade-off is a relatively thin margin and exposure to recompetes, staffing and working-capital timing.
A September contract modification for Iraq F-16 base support has been reported with a $231.8 million not-to-exceed ceiling. The reported cumulative face value of the underlying contract rises to approximately $594.2 million from $362.4 million. A ceiling measures authorized scope, not the timing of funded obligations, recognized revenue or cash receipts. Investors should distinguish the amended ceiling from incremental backlog and ask how much work is definitized, funded and profitable. Reported award details; V2X quarterly disclosures.
Industry and market: durability versus concentration
Defense sustainment can persist even when discretionary capital spending weakens, but appropriations are not the same as contractor-level economics. V2X must win or retain contracts, manage deployment and subcontractor costs, and collect receivables. The Middle East accounted for roughly $1.35 billion of the company's $4.90 billion trailing revenue, or about 28%; the US contributed roughly $3.01 billion. Geographic exposure makes regional policy and operational continuity material, even when end demand appears resilient.
One published analyst snapshot lists a Buy consensus among 12 analysts and an $89.18 average target, roughly 19% above the September 23 close. Targets are opinions rather than cash-flow evidence; coverage counts and ratings can change. Another aggregator reports a different coverage mix. Our Hold stance gives greater weight to realized margin, free cash flow and funding than to the consensus target. Source: Stock Analysis, VVX statistics and forecasts.
Technical analysis
The September 23 close of $74.94 sits below the $79.14 50-session average and below the $76.50 14-period KAMA. It remains above the roughly $71.80 200-day average cited in the available statistics snapshot. The late-July surge above $90 was not sustained; a return above both shorter-term trend lines would strengthen the case that selling pressure is easing. A break below the September $71–$72 area would instead put the longer trend in focus. These are observed price zones, not guaranteed support or entry orders. The September 23 close rebounded 2.7% from the prior session but one day does not repair a multiweek decline.
Fundamentals: growth is not the same as owner earnings
| Metric | TTM to July 2026 | FY 2025 | What matters |
|---|---|---|---|
| Revenue | 4,897 | 4,480 | Growth of about 9.3% versus full-year 2025 is a period comparison, not an annual growth rate. |
| Operating income | 204.93 | 194.27 | Trailing operating margin about 4.18%. |
| Net income | 91.85 | 77.88 | Profit margin only 1.88%. |
| Free cash flow | 130.45 | 170.07 | Down about 23% versus the prior full-year total; period bases differ. |
| Cash / total debt | 210.31 / 1,106 | 365.99 / 1,141 | Debt remains large relative to cash generation. |
The latest trailing revenue exceeds FY 2025, while trailing free cash flow falls short of FY 2025's $170.07 million. Those mismatched periods should not be presented as year-on-year rates, but they underline the right diligence priority: is growth converting to cash? At $74.94 and approximately 31.35 million shares, equity value is roughly $2.35 billion. That implies about 18× trailing free cash flow and 0.48× sales before accounting for net debt. With net debt near $896 million, enterprise value is about $3.25 billion, or roughly 10× trailing EBITDA. These are snapshots, not a discounted-cash-flow valuation. Sources: VVX financials and VVX statistics.
Decision framework: If trailing cash flow recovers toward or above FY 2025's $170 million while debt declines, the same equity value would represent a lower cash-flow multiple. If instead cash flow stays around $130 million and new programs dilute margin, a seemingly modest sales multiple could be a value trap. Neither case assumes the contract ceiling converts dollar-for-dollar into sales.
Risk analysis and next checkpoints
| Risk | What to check | Why it changes the thesis |
|---|---|---|
| Ceiling versus funded work | Definitization, obligated amount, contract timing, quarterly backlog | Unfunded scope cannot be counted as near-term revenue. |
| Program execution | Cost overruns, margin by contract mix, customer acceptance | A 4.18% operating margin offers limited error tolerance. |
| Leverage / rates | Debt repayment, interest expense, operating cash flow | Net debt of ~$896m is almost seven times trailing FCF. |
| Working capital | Receivables and cash conversion across upcoming quarters | Revenue growth that consumes cash erodes equity upside. |
| Geography and recompetes | Middle East revenue, contract extensions and renewal terms | Regional exposure and customer decisions can create discontinuities. |
The next quarterly earnings update, currently estimated for early November, should be judged on funded backlog, profit quality and operating cash flow—not simply a headline award total. Bottom line: VVX is worth following for defense-services exposure, but at this price the balance-sheet and cash-conversion tests justify patience rather than an unqualified Buy. This is research, not individualized investment advice.